Antifungal Susceptibility of 182 Fusarium Species Isolates from 20 European Centers: Comparison between EUCAST and Gradient Concentration Strip Methods.

Amphotericin B / pharmacology Antifungal Agents / pharmacology Fusarium Microbial Sensitivity Tests Voriconazole / pharmacology
EUCAST Etest Fusarium amphotericin B antifungal susceptibility comparison gradient concentration strips isavuconazole posaconazole terbinafine voriconazole

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
17 11 2021
Historique:
pubmed: 21 9 2021
medline: 15 12 2021
entrez: 20 9 2021
Statut: ppublish

Résumé

We determined the susceptibility of 182 Fusarium species isolates to five antifungal drugs (amphotericin B, voriconazole, posaconazole, isavuconazole, and terbinafine) by the EUCAST method. Based on the latest taxonomic insights, isolates collected from 20 European centers were distributed into seven complexes and 27 species. The susceptibility was variable, depending on the species. Comparison with the gradient concentration strip method, which was used for 77 isolates, showed essential agreement values for voriconazole, posaconazole, isavuconazole, and amphotericin B of 17%, 91%, 83%, and 70%, respectively.

Identifiants

DOI: 10.1128/AAC.01495-21 PMID: 34543091 PMC: PMC8597759
pubmed: 34543091
doi: 10.1128/AAC.01495-21
pmc: PMC8597759
doi:

Substances chimiques

Antifungal Agents 0
Amphotericin B 7XU7A7DROE
Voriconazole JFU09I87TR

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0149521

Références

J Fungi (Basel). 2017 Apr 26;3(2):
pubmed: 29371537
PLoS Pathog. 2016 Nov 17;12(11):e1005940
pubmed: 27855224
Diagn Microbiol Infect Dis. 2018 Oct;92(2):124-126
pubmed: 30201117
Mycoses. 2017 Mar;60(3):204-212
pubmed: 27928841
Antimicrob Agents Chemother. 2020 Jun 23;64(7):
pubmed: 32312779
Clin Microbiol Infect. 2020 Nov;26(11):1582-1584
pubmed: 32619736
Mycology. 2020 Jan 7;11(3):184-194
pubmed: 33062381
J Antimicrob Chemother. 2021 Mar 12;76(4):1063-1069
pubmed: 33326585
J Fungi (Basel). 2021 Mar 25;7(4):
pubmed: 33806102
Emerg Infect Dis. 2021 Jan;27(1):
pubmed: 33352085
Front Microbiol. 2019 Apr 10;10:737
pubmed: 31024507
Int J Antimicrob Agents. 2018 Mar;51(3):326-332
pubmed: 28705676
Antimicrob Agents Chemother. 2016 Dec 27;61(1):
pubmed: 27795379
Antimicrob Agents Chemother. 2015 Dec 07;60(2):1079-84
pubmed: 26643334
Phytopathology. 2021 Jul;111(7):1064-1079
pubmed: 33200960

Auteurs

Marion Blaize (M)

AP-HP, Groupe Hospitalier La Pitié-Salpêtrière, Service de Parasitologie Mycologie, Paris, France.
Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Paris, France.

Anne-Cecile Normand (AC)

AP-HP, Groupe Hospitalier La Pitié-Salpêtrière, Service de Parasitologie Mycologie, Paris, France.
ORCID: 0000-0002-9589-4603

Sebastien Imbert (S)

AP-HP, Groupe Hospitalier La Pitié-Salpêtrière, Service de Parasitologie Mycologie, Paris, France.

Abdullah M S Al-Hatmi (AMS)

Centre of Expertise in Mycology, Radboud University Medical Centre, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Natural and Medical Sciences Research Center, Department of Microbiology, University of Nizwagrid.444752.4, Nizwa, Oman.
ORCID: 0000-0002-5206-2647

Erja Chryssanthou (E)

Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.

Sophie Cassaing (S)

CHU Toulouse, Service de Parasitologie-Mycologie, Toulouse, France.

Christine Schuttler (C)

Laboratoire Biogroup-LCD, Levallois, France.

Lilia Hasseine (L)

CHU de Nice, Service de Parasitologie Mycologie, Nice, France.

Caroline Mahinc (C)

CHU de Saint-Etienne, Service de Parasitologie Mycologie, Saint-Etienne, France.

Damien Costa (D)

Centre Hospitalier Universitaire de Rouen, Service de Parasitologie Mycologie, Rouen, France.

Christine Bonnal (C)

AP-HP, Hôpital Bichat-Claude Bernard, Service de Parasitologie Mycologie, Paris, France.

Stéphane Ranque (S)

Aix Marseille University, IRD, AP-HM, SSA, VITROME, IHU Méditerranée Infection, Marseille, France.
ORCID: 0000-0003-3293-5276

Marc Sautour (M)

CHU de Dijon, Service de Parasitologie Mycologie, Dijon, France.

Elisa Rubio (E)

Department of Microbiology, ISGlobal Barcelona Institute for Global Health, Barcelona, Spain.
CDB, Hospital Clinic, University of Barcelona, Barcelona, Spain.

Laurence Delhaes (L)

CHU de Bordeaux, Groupe Hospitalier Pellegrin, Service de Mycologie, Bordeaux, France.

Arnaud Riat (A)

Geneva University Hospitals, Bacteriology Laboratory, Geneva, Switzerland.

Boualem Sendid (B)

CHU de Lille, Department Parasitology-Mycology, Lille, France.

Lise Kristensen (L)

Aarhus University Hospital, Department of Clinical Microbiology, Aarhus, Denmark.

Marcel Brandenberger (M)

Labor Synlab Luzern, Lucerne, Switzerland.

Dirk Stubbe (D)

Sciensano, BCCM/IHEM Collection, Mycology and Aerobiology Unit, Brussels, Belgium.

Sophie Brun (S)

AP-HP, Hôpital Avicenne, Service de Parasitologie-Mycologie, Bobigny, France.

Renaud Piarroux (R)

AP-HP, Groupe Hospitalier La Pitié-Salpêtrière, Service de Parasitologie Mycologie, Paris, France.
Sorbonne Université, INSERM, Institut Pierre Louis d'Epidemiologie et de Santé Publique, Paris, France.

Arnaud Fekkar (A)

AP-HP, Groupe Hospitalier La Pitié-Salpêtrière, Service de Parasitologie Mycologie, Paris, France.
Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Paris, France.
ORCID: 0000-0001-9954-075X

Articles similaires

Mathematical modeling of vancomycin release from Poly-L-Lactic Acid-Coated implants.

Papon Thamvasupong, Kwanchanok Viravaidya-Pasuwat
1.00
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Menthol as an effective inhibitor of quorum sensing and biofilm formation in Candida albicans and Candida glabrata by targeting the transcriptional repressor TUP1.

Pouria Khodavandi, Maryam Miri Soogh, Fahimeh Alizadeh et al.
1.00
Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol

Naturally derived 3-aminoquinuclidine salts as new promising therapeutic agents.

Doris Crnčević, Alma Ramić, Andreja Radman Kastelic et al.
1.00
Humans Microbial Sensitivity Tests Anti-Bacterial Agents Biofilms Quinuclidines

Epidemiology, clinical features, and outcome of the hospitalized patients with Kerion in Fars Province, Iran: an eleven-year retrospective study.

Fateme Khosravi, Mohammad Mahdi Parvizi, Maryam Sadat Sadati et al.
1.00
Humans Retrospective Studies Male Female Child

Classifications MeSH

questionsmedicales.fr › Composés chimiques organiques › Lactones › Amphotéricine B › Antifungal Susceptibility of 182 Fusarium...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antifongiques › Antifungal Susceptibility of 182 Fusarium...
questionsmedicales.fr › Eucaryotes › Champignons › Deuteromycota › Fusarium › Antifungal Susceptibility of 182 Fusarium...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Antifungal Susceptibility of 182 Fusarium...
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Azoles › Triazoles › Voriconazole › Antifungal Susceptibility of 182 Fusarium...